Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Metagenomics In Healthcare Market Size And Revenue Forecast Through 2030
The market for metagenomics in healthcare has experienced substantial expansion recently. Projections indicate a continued upward trend, with the market expected to increase from $2.44 billion in 2025 to $2.87 billion by 2026, demonstrating a compound annual growth rate of 17.8%. This growth during the preceding period can be ascribed to several key factors, including improvements in sequencing technologies, a rise in infectious disease occurrences, the broadening scope of microbiome research initiatives, escalating demand for diagnostic methods that do not require culturing, and the establishment of sequencing workflows suitable for clinical applications.
The metagenomics in healthcare market is poised for substantial expansion over the coming years, with projections indicating a rise to $5.46 billion by 2030, reflecting a compound annual growth rate (CAGR) of 17.5%. This upward trajectory is anticipated to be fueled by several key factors, including the wider implementation of precision diagnostics for infectious diseases, escalating investments in therapies targeting the microbiome, a broadened scope for genomic epidemiology projects, the increasing integration of artificial intelligence in the analysis of microbial data, and a heightened emphasis on tailoring treatment approaches. Significant trends expected to shape this market during the forecast period encompass the greater adoption of metagenomic diagnostic tools in healthcare environments, the expanding utilization of microbiome analysis for disease characterization, a more integrated approach to infection management using next-generation sequencing (NGS), advancements in research for personalized microbial therapies, and a strengthened focus on expediting pathogen identification.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28267&type=smp
Metagenomics In Healthcare Market Development Factors: Which Trends Are Supporting Demand?
The expanding incidence of infectious conditions is anticipated to fuel advancements in the metagenomics within healthcare sector in the future, with infectious diseases, defined as ailments stemming from detrimental microbes like bacteria, viruses, fungi, or parasites transmissible person-to-person, directly or indirectly, experiencing a surge attributed to heightened global travel accelerating pathogen dissemination across territories. Metagenomics in the healthcare domain offers a vital tool against these infectious diseases by facilitating swift and accurate pathogen detection, thereby playing a pivotal role in curbing outbreaks, alleviating diagnostic ambiguity through the examination of intricate microbial populations, enhancing patient prognoses, and informing specific therapeutic strategies, as evidenced by the UK Health Security Agency’s report in February 2024, which noted a 10.7% jump in tuberculosis cases in England to 4,850 in 2023 from 4,380 in 2022, underscoring the market’s upward trajectory driven by the escalating rate of infectious diseases.
Metagenomics In Healthcare Market Segments: Where Are The Largest Growth Opportunities?
The metagenomics in healthcare market covered in this report is segmented –
1) By Types: Sample Extraction Kits, Metagenomics Kits
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray
3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing
4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery
5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies
Subsegments:
1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits
2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits
Metagenomics In Healthcare Market Transformation Trends: Which Innovations Are Driving Change?
Companies actively participating in the metagenomics within the healthcare sector are concentrating their efforts on pioneering advancements, including the utilization of microbial community profiling, with the objective of improving the accuracy of disease detection, facilitating tailored treatment approaches, and propelling forward the field of precision medicine. This process of microbial community profiling involves a thorough examination and description of the various microorganisms present in a particular setting or specimen, employing sequencing technologies and bioinformatics methodologies to ascertain their components, variety, and functional contributions. As an illustration, in August 2024, MGI Tech Co. Ltd., a biotechnology firm originating from China, introduced a comprehensive Human Microbiome Metagenomics Sequencing Package designed to foster progress in both microbial studies and medical applications. This offering provides a fully automated, integrated workflow for microbial community profiling, enabling the efficient assessment of human microbiome characteristics, such as diversity, functionality, and associations with ailments, by leveraging proven high-throughput systems. This innovation serves to decrease the need for manual intervention, bolster the consistency of results, and lower expenses, thereby making extensive and clinical microbiome investigations more readily achievable. Researchers benefit from swift and accurate microbial identification capabilities, coupled with flexible processing volumes, which aids in the identification of significant biomarkers and the progression of research aimed at translating scientific findings into clinical practice.
Metagenomics In Healthcare Market Major Participants And Competitive Dynamics
Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., Wobble Genomics Inc.
Access The Complete Metagenomics In Healthcare Market Report:
https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report
Metagenomics In Healthcare Market Largest Region: Which Geography Holds The Highest Market Share?
North Americawas the largest region in the metagenomics in healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
